Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Zörner, Björn; Filli, Linard; Reuter, Katja; Kapitza, Sandra; Lőrincz, Lilla; Sutter, Tabea; Weller, David; Farkas, Melinda; Awai Easthope, Chris; Czapliński, Adam; Weller, Michael; Linnebank, Michael

doi:10.1177/1352458515622695

Public

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Published in Multiple Sclerosis Journal • Jan 13, 2016

Authors:

Björn Zörner

Linard Filli

Katja Reuter

Abstract

BACKGROUND: Prolonged-release fampridine (PR-fampridine, 4-aminopyridine) increases walking speed in the timed 25-foot walk test (T25FW) in some patients (timed-walk responders) with multiple sclerosis (MS). OBJECTIVE: To explore the effects of PR-fampridine on different aspects of walking function ...

Subject

Gait

Preferred walking speed

Physical medicine and rehabilitation

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!